Browse All

Current Filters

CLEAR FILTER x

TITLE

Demographic and Clinical Characteristics of an MS and NMO Registry Cohort in Ghana

Author:Duodu, Fiifi   Badu-Prempeh, Nana Boakye Agyeman   Pekyi-Boateng, Prince   Agyekum, Ruth   Akpalu, Albert   Saylor, Deanna   

Session Name:P9: Multiple Sclerosis: NMOSD, MOGAD, and Other Mimickers of MS  

Topic:Multiple Sclerosis  

Program Number:P9.006  

Author Institution:Korle-Bu Teaching Hospital Medical department, ACCRA, Ghana  Johns Hopkins Bloomberg School of Public health, Baltimore, MD  University of Utah Health, Salt Lake City, UT  Johns Hopkins School of public health, Accra, Ghana  School of Medicine and Dentistry, Accra, Korle Bu, Ghana  Johns Hopkins Hospital, Baltimore, MD  

Prevalence of Inflammatory Bowel Disease Among Patients with MS, NMOSD, and MOGAD Attending NYU MS Care Center

Author:Akers, Carolyn   Hashemzadeh, Taymour   Kister, Ilya   

Session Name:P9: Multiple Sclerosis: NMOSD, MOGAD, and Other Mimickers of MS  

Topic:Multiple Sclerosis  

Program Number:P9.007  

Author Institution:New York University Grossman School of Medicine, New York, NY  

A Real-world Study of Inebilizumab for Neuromyelitis Optica Spectrum Disorders

Author:Shen, Ang   Liu, Hongbo   

Session Name:P9: Multiple Sclerosis: NMOSD, MOGAD, and Other Mimickers of MS  

Topic:Multiple Sclerosis  

Program Number:P9.008  

Author Institution:The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China, People's Republic of  

Treatment and Prognosis for Marburg Multiple Sclerosis: A Systematic Review of Case Reports

Author:Javier Murillo, Nair   Lapeyre Rivera, Andre   Duran Pecho, Juan   Tello Serra, Ariadna   VERASTEGUI LARICO, SEBASTIAN   Alegre, Ivan   Pascual-Guevara, Milagros   Pacheco, Niels   Uwishema, Olivier   

Session Name:P9: Multiple Sclerosis: NMOSD, MOGAD, and Other Mimickers of MS  

Topic:Multiple Sclerosis  

Program Number:P9.009  

Author Institution:Facultad de Medicina, Universidad de Piura, Lima, Peru, San Isidro, Peru  Sociedad Científica de San Fernando, Facultad de Medicina, Universidad Nacional Mayor de San Marcos, Lima, Perú, Lima, Peru  Harvard Medical School, Boston, MA  Oli Health Magazine Organization(OHMO), Trabzon, Turkey  

Comparative Analysis of Disease-modifying Treatments for Double Seronegative Neuromyelitis Optica Spectrum Disorder

Author:Mahler, Joao Vitor   Vallejos, Gerome   Mikami, Takahisa   Bilodeau, Philippe-Antoine   Silva, Guilherme   Apostolos-Pereira, Samira   Leles, Bruna   Manzano, Giovanna   Gibbons, Emily   Uawitha, Ekdanai   Ramprasad, Manisha   Sezen, Ahmetcan   Pasquale, Olivia   Kim, Angie   Vij, R   

Session Name:P9: Multiple Sclerosis: NMOSD, MOGAD, and Other Mimickers of MS  

Topic:Multiple Sclerosis  

Program Number:P9.010  

Author Institution:Division of Neuroimmunology & Neuroinfectious Disease, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, BOSTON, MA  Division of Neuroimmunology & Neuroinfectious Disease, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, New York, NY  Division of Neuroimmunology & Neuroinfectious Disease, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Cambridge, MA  Departamento de Neurologia, Hospital das Clínicas da Faculdade de Medicina da USP, SÃO PAULO, Brazil  Departamento de Neurologia, Hospital das Clínicas da Faculdade de Medicina da USP, Sao Paulo, Brazil  Walton Centre NHS Foundation Trust, Liverpool, United Kingdom  Case Western Reserve University School of Medicine, Cleveland, Ohio, Cleveland Heights, OH  Koç University, Istanbul, Turkey  NYU Grossman School of Medicine, New York, NY  NYU School of Medicine, New York, NY  Koc University School of Medicine, Istanbul, Turkey  Multiple Sclerosis and Neuroimmunology Program, University Hospitals Cleveland Medical Center, Cleveland, OH  Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates